Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermoscent, the brand name for Laboratoire de Dermo-Cosmétique Animale (LDCA), is a French veterinary company specializing in innovative dermo-care solutions for companion animals. Founded in 2003 and based in Castres, the company develops clinically proven skincare products for dogs, cats, and horses using natural active ingredients. Their portfolio includes the pioneering Essential 6 spot-on, as well as the ATOP 7 and PYO ranges, which address conditions such as atopic dermatitis, skin infections, and barrier dysfunction. Dermoscent's products are distributed globally and are recognized for their physiological approach to animal dermatology. In June 2024, the company was acquired by Ceva Santé Animale, a global leader in the animal health industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermoscent.